Cancer carers to cost UK employers £8.5bn in 2025

Impact on finances, time, careers

Cameron Roberts
clock • 3 min read

Cancer support specialist, Reframe Cancer, has released research which showed UK employers will be subject to a £8.5 billion cancer carer absence cost bill in 2025.

The research, which surveyed 442 cancer carers in the UK, stated that employees acting as a carer for loved ones with cancer spent an average of 16 hours per week providing care alongside full time employment. Carers primarily cared for a parent (36%); a relative (28%); close friend (14%); and a husband or wife (13%). Most carers take on the role post diagnosis (49%), whilst 31% take the role during treatment and 14% begin caring before diagnosis. When employees are caring for a loved one, the survey indicated they took an average of 3.5 days, with carers taking an additional three da...

To continue reading this article...

Join COVER for free

  • Unlimited access to real-time news, key trend analysis and industry insights.
  • Stay on top of the latest developments around health and wellbeing, diversity and inclusion and the cost of living crisis.
  • Receive breaking news stories straight to your inbox in the daily newsletter.
  • Members only access to monthly programme 'The COVER Review'
  • Be the first to hear about our CPD accredited events and awards programmes.

Join now

 

Already a Cover member?

Login

More on Employee Benefits

Broadstone launches employee benefits platform for SMEs

Broadstone launches employee benefits platform for SMEs

Access to a “ready-made” selection of benefits

Jaskeet Briah
clock 12 November 2026 • 1 min read
Three quarters of employees would use workplace cancer screening and tests

Three quarters of employees would use workplace cancer screening and tests

Free appointments are the key driver

Jaskeet Briah
clock 09 November 2026 • 2 min read
Budget 26: OBR downgrades IPT forecast

Budget 26: OBR downgrades IPT forecast

£0.2bn reduction

Cameron Roberts
clock 28 October 2026 • 1 min read